A new trading day began on Monday, with Citius Pharmaceuticals Inc (NASDAQ: CTXR) stock price down -11.26% from the previous day of trading, before settling in for the closing price of $1.82. CTXR’s price has ranged from $0.65 to $12.84 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 20.90%. Meanwhile, its annual earnings per share averaged 50.34%. With a float of $17.41 million, this company’s outstanding shares have now reached $18.47 million.
Citius Pharmaceuticals Inc (CTXR) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Citius Pharmaceuticals Inc is 5.74%, while institutional ownership is 4.94%.
Citius Pharmaceuticals Inc (CTXR) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -5.8 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 50.34% per share during the next fiscal year.
Citius Pharmaceuticals Inc (NASDAQ: CTXR) Trading Performance Indicators
Here are Citius Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.96, a number that is poised to hit -0.43 in the next quarter and is forecasted to reach 0.37 in one year’s time.
Technical Analysis of Citius Pharmaceuticals Inc (CTXR)
The latest stats from [Citius Pharmaceuticals Inc, CTXR] show that its last 5-days average volume of 0.92 million was inferior to 1.13 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 49.34%.
During the past 100 days, Citius Pharmaceuticals Inc’s (CTXR) raw stochastic average was set at 49.71%, which indicates a significant increase from 40.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.2219 in the past 14 days, which was higher than the 0.1645 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3167, while its 200-day Moving Average is $1.4875. Now, the first resistance to watch is $1.7617. This is followed by the second major resistance level at $1.9083. The third major resistance level sits at $1.9867. If the price goes on to break the first support level at $1.5367, it is likely to go to the next support level at $1.4583. The third support level lies at $1.3117 if the price breaches the second support level.
Citius Pharmaceuticals Inc (NASDAQ: CTXR) Key Stats
With a market capitalization of 29.83 million, the company has a total of 17,012K Shares Outstanding. Currently, annual sales are 0 K while annual income is -39,140 K. The company’s previous quarter sales were 0 K while its latest quarter income was -8,790 K.
